These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8413956)

  • 21. [Gaucher's disease with D409H/D409H genotype. evolution with enzyme replacement therapy].
    Castelló Girona F; Domínguez Luengo C; del Toro Riera M; Chabás Bergon A
    An Esp Pediatr; 2001 Mar; 54(3):310-2. PubMed ID: 11262263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Gaucher disease: diagnosis and treatment].
    Fumić K; Stavljenić-Rukavina A; Mrsić M; Potocki K
    Acta Med Croatica; 2004; 58(5):353-8. PubMed ID: 15756799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Diagnosis and therapy of Gaucher disease. Current recommendations of German therapy centers in the year 2000].
    Niederau C; Rolfs A; vom Dahl S; Häussinger D; Poll LW; Mengel E; Beck M
    Med Klin (Munich); 2001 Jan; 96(1):32-9. PubMed ID: 11210487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progressive myoclonic epilepsy and horizontal gaze palsy: a rare aetiology.
    Singh R; Choudhary A; Kumar AS; Goyal MK
    BMJ Case Rep; 2017 Dec; 2017():. PubMed ID: 29237663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enzymic differentiation of neurologic and nonneurologic forms of Gaucher's disease.
    Glew RH; Daniels LB; Clark LS; Hoyer SW
    J Neuropathol Exp Neurol; 1982 Nov; 41(6):630-41. PubMed ID: 6813430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improvement In Symptoms Of Gaucher's Disease By Enzyme Replacement Therapy.
    Mazher W; Ali J; Abubakar S; Basar S; Murtaza G
    J Ayub Med Coll Abbottabad; 2018; 30(3):479-481. PubMed ID: 30465391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Communicating hydrocephalus in a patient with Gaucher's disease type 3.
    Shiihara T; Oka A; Suzaki I; Ida H; Takeshita K
    Pediatr Neurol; 2000 Mar; 22(3):234-6. PubMed ID: 10734257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Marked elevation of serum angiotension-converting enzyme and hepatic fibrosis containing long-spacing collagen fibrils in type 2 acute neuronopathic Gaucher's disease.
    Silverstein E; Friedland J; Vuletin JC
    Am J Clin Pathol; 1978 Apr; 69(4):467-71. PubMed ID: 206129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gaucher's disease and pregnancy.
    Fasouliotis SJ; Ezra Y; Schenker JG
    Am J Perinatol; 1998 May; 15(5):311-8. PubMed ID: 9643638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Taliglucerase alfa for the treatment of Gaucher's disease.
    Haddley K
    Drugs Today (Barc); 2012 Aug; 48(8):525-32. PubMed ID: 22916340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective study of neurological responses to treatment with macrophage-targeted glucocerebrosidase in patients with type 3 Gaucher's disease.
    Schiffmann R; Heyes MP; Aerts JM; Dambrosia JM; Patterson MC; DeGraba T; Parker CC; Zirzow GC; Oliver K; Tedeschi G; Brady RO; Barton NW
    Ann Neurol; 1997 Oct; 42(4):613-21. PubMed ID: 9382473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pediatric non-neuronopathic Gaucher disease: presentation, diagnosis and assessment. Consensus statements.
    Grabowski GA; Andria G; Baldellou A; Campbell PE; Charrow J; Cohen IJ; Harris CM; Kaplan P; Mengel E; Pocovi M; Vellodi A
    Eur J Pediatr; 2004 Feb; 163(2):58-66. PubMed ID: 14677061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oculomotor apraxia in a case of Gaucher's disease with homozygous T1448C mutation.
    Tsai LP; Sue WC; Hwu WL; Lin KH; Wang TR
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1996; 37(1):52-5. PubMed ID: 8936012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of the 1226 (Jewish) mutation for Gaucher's disease by color PCR. A means for studying the gene frequency of the disorder.
    Zimran A; Kuhl WC; Beutler E
    Am J Clin Pathol; 1990 Jun; 93(6):788-91. PubMed ID: 2346136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenotypic continuum of type 2 Gaucher's disease: an intermediate phenotype between perinatal-lethal and classic type 2 Gaucher's disease.
    Ben Turkia H; Tebib N; Azzouz H; Abdelmoula MS; Ben Chehida A; Caillaud C; Ben Dridi MF
    J Perinatol; 2009 Feb; 29(2):170-2. PubMed ID: 19177047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical heterogeneity among patients with Gaucher's disease.
    Sidransky E; Ginns EI
    JAMA; 1993 Mar; 269(9):1154-7. PubMed ID: 8433471
    [No Abstract]   [Full Text] [Related]  

  • 37. Phenotype, diagnosis, and treatment of Gaucher's disease.
    Grabowski GA
    Lancet; 2008 Oct; 372(9645):1263-71. PubMed ID: 19094956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Gaucher's disease. Longitudinal-study in 17 patients in a 10-year period (1970-1980) (author's transl)].
    Di Rocco M; Salemi D; Borrone C
    Pediatr Med Chir; 1981; 3(6):487-94. PubMed ID: 7343946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Report of the Spanish Gaucher's disease registry: clinical and genetic characteristics.
    Giraldo P; Pocoví M; Pérez-Calvo J; Rubio-Félix D; Giralt M
    Haematologica; 2000 Aug; 85(8):792-9. PubMed ID: 10942924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gaucher's disease;thirty-two years experience at Siriraj Hospital.
    Tanphaichitr VS; Suvatte V; Mahasandana C; Sachapong P; Veerakul G; Kankirawatana S; Wasant P
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():143-7. PubMed ID: 11400753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.